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Abstract   
Diffusion in cell membranes is not just simple two-dimensional Brownian motion but typically depends 
on the timescale of the observation. The physical origins of this anomalous sub-diffusion are unresolved, 
and model systems capable of quantitative and reproducible control of membrane diffusion have been 
recognized as a key experimental bottleneck. Here we control anomalous diffusion using supported lipids 
bilayers containing lipids derivatized with polyethylene glycol (PEG) headgroups. Bilayers with specific 
excluded area fractions are formed by control of PEG-lipid mole fraction. These bilayers exhibit a switch 
in diffusive behavior, becoming anomalous as bilayer continuity is disrupted. Using a combination of 
single-molecule fluorescence and interferometric imaging, we measure the anomalous behavior in this 
model over four orders of magnitude in time. Diffusion in these bilayers is well-described by a power-
law dependence of the mean square displacement with observation time. Anomaleity in this system can 
be tailored by simply controlling the mole fraction of PEG-lipid, producing bilayers with diffusion 
parameters similar to those observed for anomalous diffusion in biological membranes. 
Introduction 
Diffusion is an essential transport mechanism in membrane biology, vital for a wide range of 
biological function including protein organization (1), signalling (2, 3) and cell survival (4). 
Interestingly, such living systems do not, in general, display the Brownian motion predicted by a 
simple random walk model, and instead exhibit ‘anomalous’ diffusion (5) where the diffusivity is 
dependent on the timescale of observation. This phenomenon has been reported both for three-
dimensional diffusion in the cell cytosol (6) and two-dimensional diffusion in the plasma membrane 
(7–9). 
Why and how anomalous diffusion exists in the plasma membrane has been the subject of 
considerable investigation (reviewed in (10)). The common underlying mechanism is thought to relate 
to the complex environment found in the cell membrane (11); and the presence of slower-moving 
obstacles (12, 13), heterogeneous diffusion (14), transient binding (15), pinning sites, and 
compartmentalization (11, 16, 17) have all been suggested as potential contributors to anomaleity in 
membrane diffusion. Here we focus on confinement, where in cellular membranes anomalous 
diffusion is reported in a large number of cell types (16–18) and with barrier length-scales on the 
order of tens to hundreds of nanometers. Overall this work has led to the adoption of a 
compartmentalized model of the cell membrane, where the cytoskeleton-membrane interactions 
impose barriers to diffusion (11, 15). 
Artificial lipid bilayers have played a key role in improving our understanding of anomalous diffusion 
(19–24), where both phase separation (20) and protein binding (21) in supported lipid bilayers (SLBs) 
have been used to generate anomalous diffusion. Simulations have also been vital in advancing our 
understanding, with much pioneering (5, 25, 26) and recent (27–32) work in this area. In particular, 
simulations have helped elucidate the role of mobile and immobile obstacles in causing anomalous 
behavior (12, 13). Relevant to our work, simulations have also been used to better interpret single 
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particle tracking data (33) and provide methods to discriminate between classes of anomalous 
diffusion (34). 
Despite these advances, discriminating between the different possible molecular mechanisms that give 
rise to anomalous diffusion in vivo remains challenging. Discrepancies between results from different 
techniques arise due to their different timescales of measurement, making it difficult to isolate the 
underlying cause of any observed anomalous diffusion. This is most clearly highlighted by Saxton et 
al., who published a call for ‘a positive control for anomalous diffusion’ as a solution to this problem 
(10). This positive control would be a simple and reproducible experimental model exhibiting ‘readily 
tuneable’ anomalous diffusion spanning several orders of magnitude in timescale, that would enable 
direct comparison of different measurement techniques. 
Here we seek to address this call by engineering a simple experimental model in which it is possible 
to select the extent of anomalous behavior. We take advantage of previous work on the disruption of 
SLB formation by PEG-DPPE (35) to control nanoscale obstacle formation in a bilayer (Fig. 1A). By 
varying the PEG-DPPE composition in a bilayer, we expect that an increased fraction of polymer in 
the brush regime will result in the formation of specific defects in the bilayer, similar to interfacial or 
grain boundary defects caused by phases separating mixtures (36). Similar defects have also been 
reported using Atomic Force Microscopy (AFM) of incomplete SLB formation from small 
unilamellar vesicles (SUVs) (37), as well as in SLBs formed in the presence of membrane active 
peptides (38). 
In exploiting membrane defects as a tool to help us understand anomalous diffusion we must highlight 
the fact these defects are not the cause of anomalous diffusion in cells. Despite this limitation, our 
simple model does allow the generation of lipid membranes with tuneable anomalous parameters 
relevant to the range reported in cells. Thus, we can make specific changes to the nature and size of 
these obstacles in order to better understand their effects on anomalous behavior, and help benchmark 
different experimental techniques. 
The complex nanometer-scale confinement reported in cell membranes gives rise to anomalous 
behavior that spans from microseconds to seconds. Thus to properly characterize anomalous 
diffusion, it is important to apply techniques capable of studying these timescales. To access this 
range of timescales, we exploit a combination of two single-molecule methods: Total Internal 
Reflection Fluorescence (smTIRF) (39) and Interferometric Scattering (iSCAT) microscopy (40, 41). 
smTIRF enables the tracking of single fluorescently-labeled lipid in these membranes with super-
resolved precision (Fig. 1C). Using gold nanoparticles, iSCAT enables tracking of lipid diffusion at 
sub-millisecond time resolutions (Fig. 1D). In combination, these techniques allow us to characterize 
nanoscopic diffusion using single-particle tracking that spans over four orders of magnitude in time. 
Theory 
Anomalous diffusion describes random molecular motion that does not display a linear scaling of the 
second moment with time. The most common model for anomalous diffusion is to allow the second 
moment to scale as a power of time (5, 42), 
2Δ 4ΓΔ ,r t   (1)  
where α is the anomalous exponent and 
2Δr  is the mean squared displacement. Here, the more 
familiar diffusion coefficient, D, is replaced by Γ , the anomalous transport coefficient. Given the 
form of equation 1, α can be determined from the gradient of a logarithmic plot of 
2Δ / 4Δr t  vs. 
Δt . 
The transport coefficient Γ  is somewhat more difficult to interpret than the anomalous exponent α, as 
it has dimension of [L]
2
/[T]
α
, thus its dimensions are changing for different degrees of anomalous 
behavior. This apparent problem can be overcome by de-dimensionalizing the observation time (5) 
using a ‘jump time’, τ: 
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1
2 ΔΔ 4 Δ .
t
r D t   (2)  
τ can be interpreted in terms of a length scale (λ) associated with the anomalous behavior in 2D 
( 4D ). Combining equations 1 and 2 yields 
10 10log Γ / 1 log ,D   (3)  
and a linear scaling of 
10log Γ / D  with α is expected. 
Materials and Methods 
Materials 
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC), 1,2-diphytanoyl-sn-glycero-3-phosphocholine 
(DPhPC) and 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-cap-biotinyl (biotin-DOPE) were 
purchased from Avanti Polar Lipids (Alabaster, AL). Texas Red 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanol-amine (TR-DHPE) triethylammonium salt and 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine-N-[methoxy(polyethylene glycol) - 1000/2000/5000] ammonium salt 
(PEG1/2/5K-DPPE) were purchased from Invitrogen (Eugene, OR). Goat antibiotin-conjugated 20 
nm gold nanoparticles were purchased from BBI (Cardiff, UK). Standard phosphate-buffered saline 
(PBS) tablets (P4417), hexadecane (296317) and silicone oil AR20 (10836) were purchased from 
Sigma-Aldrich (St-Louis, MO). All chemicals and solvents were of analytical grade and used without 
further purification. 18.2 MΩ  cm water (Merck Millipore, Billerica, MA) was used to prepare all 
solutions. 
Supported Lipid Bilayers 
Glass coverslips (VWR, Menzel Gläser #1) were cleaned using stepwise sonication with detergent 
(Decon-90), water, and propan-2-ol before being stored in water until use. Immediately before use the 
glass was dried under nitrogen and cleaned with oxygen plasma for 3 minutes (Diener Electronic, 
Femto). A well was created on each coverslip using vacuum grease (Dow Corning high vacuum 
grease). Lipid mixtures in chloroform (1 mg mL 1 1 DOPC; 10 6 mol% each TR-DHPE and biotin-
DOPE) were doped with varying amounts of PEG-lipids to span a range of 0 to 10 mol%. Lipid 
mixtures were dried under nitrogen and placed under vacuum overnight. The dried lipids were 
hydrated in water and votexed before tip sonication for 15 minutes. The resulting clear, SUV 
suspension was centrifuged (3 minutes; 14000 g) before the supernatant was separated and retained. 
50 μ L of SUV stock was diluted 1:1 in buffer (PBS pH 7.4) and added to the chamber immediately. 
The vesicles were incubated for 60 minutes before the membranes were washed with de-gassed water 
and PBS. 
Atomic Force Microscopy 
AFM was carried out using a BioScope Resolve (Bruker, MA). An SNL-10B cantilever was used with 
a spring constant of 0.12 N m
1
. The instrument was run in peak-force tapping mode with a 
maximum applied force of 40 pN. Image binarization in FIJI (43) was used to determine bilayer area 
fraction. Auto-correlation of the images was performed in FIJI; the resultant plots were then radially-
averaged before Lorentzian fitting to extract FWHMs (Fig. S3) 
Fluorescence Recovery After Photobleaching 
Fluorescence recovery after photobleaching (FRAP) experiments were carried out as described by 
Axelrod et al. (44) (Fig. 4b). Briefly, a DOPC SLB with 0.5 mol% TR-DHPE, was subjected to 
intense 532 nm laser light through a small iris for 5 s. The iris was then opened, the illumination 
intensity reduced, and the bilayer imaged every 5 s for the following 20 min. Fluorescence recovered 
in the region where the intense laser light had caused strong photobleaching. Image analysis of this 
recovery process yielded the diffusivity of the TR-DHPE in the SLB. This was quantified by fitting 
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with a modified Bessel function as outlined by Soumpasis (45). This fitting method is only applicable 
to bilayers exhibiting normal diffusion and as such, the bilayer containing PEG(2K)-DPPE at 2.6 
mol% was not quantified. 
Total Internal Reflection Fluorescence Microscopy 
A 532 nm continuous-wave laser was launched into an inverted microscope (Eclipse TiE; Nikon) and 
focussed at the back aperture of the objective lens (60  TIRF oil-immersion NA 1.49, Nikon, 1.4 
kW cm
2
 at the sample) such that total internal reflection occurred. The resultant fluorescence signal 
was transmitted through dichroic (ZT532rdc) and bandpass (605/55) filters (both Chroma, Bellows 
Falls, VT) before being imaged onto an electron-multiplying CCD (iXon+ 860; Andor) at 200 Hz. 
Interferometric Scattering Microscopy 
A custom microscope was constructed to conduct these measurements as described (46, 47). Briefly, a 
639 nm laser beam (Toptica, Graefelfing, Munich) was directed through a polarizing beam splitter 
and quarter wave plate (both Thorlabs, Newton, NJ) before reaching a focus at the back aperture of an 
objective lens (100  oil immersion NA 1.49 Nikon). Light scattered from the coverslip interface and 
the object of interest produce an interference pattern which is returned through the beam splitter. The 
resultant signal was then magnified (overall magnification 354 ) and imaged onto a CMOS camera 
(Phantom Miro 310) where a 128  128 region of interest was recorded. To track gold nanoparticle 
(AuNP) -labelled lipids, a SLB was formed as described above and 5 μ L of anti-biotin OD10 40 nm 
AuNP were added. After 2 hours incubation, the SLB was washed thoroughly with buffer to remove 
unbound nanoparticles before imaging. Image stacks of 10000 frames were recorded at 100 kHz. 
Image stacks were then temporally-averaged to 5 kHz to improve signal:noise for tracking. 
Single-Particle Tracking 
Single-particle tracking of both smTIRF and iSCAT data was performed using the TrackMate plugin 
for FIJI (48). Briefly, spots were detected in each frame using a Laplacian of Gaussian (LoG) filter. 
Tracks were then generated by linking these detected spots together using a simple linear assignment 
problem (LAP) tracker. The output from this was a collection of tracks containing the space-time co-
ordinates of each point in the track. This data was subsequently used to obtain mean-squared 
displacements for different observation times, which in turn was used to obtain diffusivity values via 
the random walk model of diffusion. For iSCAT experiments, A median image was first subtracted 
from all raw images before tracking, again using TrackMate. Gaussian fitting was used to estimate the 
localisation precision for smTIRF (25.7 nm at 200 Hz) and iSCAT (10.3 nm at 5 kHz). 
Droplet Interface Bilayers 
Droplet Interface Bilayers (DIBs) were used for control experiments to create defect free bilayers to 
compare with our results from SLBs (Fig 5). ‘Lipid in’ DIBs were prepared following our previous 
protocol (49). Briefly, SUVs of DPhPC only and DPhPC + PEG(2K)-DPPE were prepared as 
described above and diluted with buffer to a final concentration of 0.5 mg ml
1
. 100 nl droplets of 
SUV solution were pipetted into a microfabricated tank containing hexadecane and incubated for 40 
min. DPhPC (8.9 mg ml
1
 in 9:1 hexadecane:silicone oil) was prepared from chloroform stock. A 
microfabricated PMMA device containing the agarose layer on a glass coverslip was incubated with 
the DPhPC in oil solution for 20 min. Incubated droplets were then added to the device and left for 10 
min to allow bilayer formation before imaging. 
Monte Carlo Simulations 
To support our experimental data and help understand diffusion in this system we created a simple 2D 
Monte Carlo random walk in the presence of defects. For each of 200 simulated particles, two 
separate random walks were created (corresponding to the displacement in x and y coordinates) using 
a pseudorandom number generator (Mersenne Twister) with periodic boundary conditions. To mimic 
the defects observed in our AFM data, we defined a fixed circular obstacle of radius R at the centre of 
a square unit cell, of side s, shown in Figure 6A. With each step of the random walk, the new 
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coordinates were tested to see if they were inside an obstacle or not. If they were, then that step was 
rejected, and a new one generated. The resulting co-ordinates for each simulated particle were 
subsequently processed into tracks an analysed in an identical manner to the experimental data. These 
tracks represent diffusing particles that have been hindered due to the presence of obstacles, and 
exhibited anomalous diffusion as expected. 
Results 
Supported Lipid Bilayers 
DOPC SLBs doped with PEG-DPPE (0 - 10 mol% PEG-DPPE; 1,2, & 5 kDa PEG) were first 
examined using AFM (Fig. 1B): As PEG-DPPE content increased, small defects appeared in the 
bilayer. Further increases in the concentration of PEG-DPPE resulted in the growth of these interfacial 
defects, until the system crosses the percolation threshold, leading to confined bilayer patches. Image 
binarization and spatial autocorrelation were used to calculate the excluded area fraction and defect 
length scale. The diffusive properties of these bilayers were assessed by single-particle tracking from 
both smTIRF and iSCAT image sequences. smTIRF was used to track individual Texas Red-labelled 
lipids (
610  mol% TR-DHPE) at 200 Hz; iSCAT tracked 40 nm antibiotin-conjugated gold 
nanoparticles (AuNPs) tethered to biotinylated lipids at 5 kHz. 
For smTIRF, as the concentration of PEG(2K)-DPPE was increased from 0 to 5 mol%, the gradient of 
the 
2log Δ / 4Δr t  vs. log Δt  plot deviates from zero (Fig. 2A). Figure 2B shows the equivalent 
PEG(2K)-DPPE dataset arising from iSCAT. Similar plots were produced for PEG(1K)- and 
PEG(5K)-DPPE (Fig. S1). Gradients extracted from these plots ( 1) permit calculation of the 
anomalous exponent, α, while the y-axis intercept reports the transport coefficient, Γ . The values of α 
for all three PEG molecular weights are collated in Figure 2C; α transitions from 1 (free diffusion) to 
0 (confined diffusion). Similary, Γ  varies from free diffusion to confined as the mol% PEG-DPPE 
increases (Fig. 2D). These data were fit to a simple sigmoid. Both smTIRF and iSCAT measurements 
give rise to the same trend, and are plotted together (Figs. 2C&D, Table S1). 
Binarization of our AFM data enabled us to estimate the bilayer area fraction as a function of mol% 
PEG-DPPE (Fig. 3A). Using this calibration, we then examined the variation in anomalous diffusion 
as a function of excluded area fraction. For α (Fig. 3B) and Γ  (Fig. 3C), the sigmoids for the three 
different PEG molecular weights now overlap, showing the same trend with excluded area fraction. 
For α vs. excluded area fraction a single sigmoid fit yields a midpoint at 0.232 0.001 . 
Limiting values for Γ  differ as expected between smTIRF and iSCAT experiments due to the size 
difference of fluorescently labelled lipids and AuNPs (50). It is also worth emphasizing that as Γ  
scales with α, only points with the same α values can really be compared directly. 
Supported Lipid Bilayer Recovery 
We sought to determine if anomalous diffusion in these bilayers is due to membrane defects. 
Following SPT of a bilayer with 2.6% PEG(2K)-DPPE, we performed experiments where additional 
DOPC SUVs were added to subsequently ’repair’ the membrane. smFRET tracking of individual 
lipids in these experiments showed a recovery and return to normal diffusion following SUV addition 
(Fig. 4A). We also performed FRAP measurements on these membranes in order to measure the 
overall properties of the bilayer (Fig. 4B). Prior to SUV addition, recovery of fluorescence was 
essentially absent, with a large slow and immobile fraction. Following addition of SUVs, membranes 
recovered their fluorescence with a diffusion coefficient ( 1.75μD m 2  s 1 ) comparable to a pure 
DOPC bilayer ( 1.81μD m 2  s 1 ) , indicative of a contiguous bilayer without confined diffusion. 
Droplet Interface Bilayers 
We used Droplet Interface Bilayers (DIBs) (49, 51) to create defect-free bilayers (Fig. 5A). In DIBs, 
defects would result in conductance across the bilayer, unstable droplets and ultimately bilayer 
rupture (52). DIBs with 2.6 or 5.0 mol% PEG(2K)-DPPE; 
610  mol% TR-DHPE) were formed. 
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Single-particle tracking using smTIRF showed normal diffusion even for 5.0 mol% PEG-DPPE, well 
above the threshold value for anomalous behaviour in SLBs. Bilayers containing even 5.0 mol% 
PEG(2K)-DPPE exhibited normal diffusion (Fig. 5B). 
Monte Carlo Simulations 
To help improve our understanding of these results we constructed a Monte-Carlo simulation of 
anomalous diffusion where a periodic square lattice of circular, immobile obstacles of radius R was 
simulated using a unit cell with side-length s (Fig. 6A). A discrete-time random walk was subject to 
the constraint that the walk cannot enter the circular obstacle. As expected from previous similar 
Monte-Carlo simulations (5), anomalous behavior arises as the excluded area fraction was increased 
(Fig. 6B); and again a plateau of normal diffusion at short times was observed. When values were 
collated, a sigmoidal trend was present with 0  reached at an area fraction of 0.773, near to the 
percolation threshold for simple fixed circular obstacles on a square lattice (0.785). Γ  was best fit by 
a double-sigmoid (Fig. 6D, Table S1). A linear variation of 
10log Γ / D  with α was also reproduced 
from our simulation, consistent with equation 3. The characteristic length scales (λ) calculated from 
both simulation (Fig. 7A) and experiment (Fig. 7B) are summarized in Table S2. 
Reproducing specific anomalous diffusion 
To assess the usefulness of this model to produce bilayers with defined anomalous diffusion, we 
examined the variation of measured α with that predicted from a specific mol %  PEG-DPPE (Fig. 8). 
From this analysis, we are able to reproduce bilayers with defined α values with a precision of 0.065 
from the root mean squared deviation of target vs. measured values of α. 
Limitations 
We address directly the limitations of this model system. Confinement in cell membranes is clearly 
not created by membrane defects in supported bilayers, but rather is (arguably) most likely due to the 
excluded area created by membrane proteins and their interactions with lipids. However, despite these 
fundamental differences, both systems result in a similar restriction to free diffusion in the bilayer, 
and a parallel can be drawn between the excluded area controlled in this simple model and that 
inaccessible to diffusing species in cell membranes. This clearly does not exclude other potential 
mechanisms as the cause of anomaleity in cells, but it does provide a model system with well-defined 
parameters, with which to test predictions about anomalous diffusion in lipid membranes. 
Theory predicts that in a system with finite hierarchy, the diffusion will return to normal behavior 
(with a reduced diffusion coefficient) at sufficiently long observation times (53). Figure 2A shows 
that over the time scales observed in these experiments, the diffusion here remains anomalous. As 
normal behavior returns at around 100 ms for similarly sized compartments in cells (17), our model 
must not possess the restricted range of compartment size that are presumably present in cell 
membranes. Further control of bilayer defect scaling would enable a return to normal diffusion at 
these timescales; for example by nano-patterning of the substrate before SLB formation (54). 
However, this is beyond the scope of this work. 
Discussion 
These experiments show the presence of PEG-DPPE can disrupt SLB formation leaving a network of 
defects whose area fraction is dependent on the concentration. It is bilayer continuity (not the 
presence of PEG-DPPE as a static obstacle) that causes this anomalous behavior. Controls (Fig. 4) 
confirm that normal diffusive behavior can be rescued by filling in bilayer defects, or exploiting 
bilayers where defects are inhibited (Fig. 5). 
The variation of α and Γ  with excluded area fraction shows a sigmoidal transition between free and 
confined diffusion. This behaviour enables us to control anomalous behaviour and select specific α 
values by varying the mol% of PEG-DPPE (Fig. 8), with a turning point that is itself tuneable based 
on PEG length (Fig. 2C). Lipid solutions in organic solvents are straightforward to produce, and our 
method can be used to create a model bilayer with specific α. Reported α values from both molecular 
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dynamics simulations (27) and measured in cell membranes (17, 55–57) span a wide range (typically 
0.45 - 0.7). Using our model we can make specific and controlled changes to defect extent that 
encapsulate this range, providing an opportunity to use this simple model to recreate parameters that 
would be representative of anomalous diffusion observed in vivo, noting again that although the 
characteristics of this diffusion can be recreated, the underlying mechanism (defects in a lipid bilayer) 
is clearly different. 
We also considered fractional moment analysis to explore if our model exhibited strong or weak self-
similarity in diffusion (58) (Fig. S4), however this analysis showed strong self-similarity for all 
fractional moments. 
By using two single-particle microscopy techniques we have sampled the anomalous behavior of this 
model over four orders of magnitude of time. Alone, fluorescence microscopy cannot access the 
divergence of the diffusivity at short times and the onset of anomalous behavior. The high frame rate 
of iSCAT also presents its own challenges in data management, preventing us from probing all the 
relevant timescales with a single technique. 
Perhaps of greatest interest is the difference between plots of 10log Γ / D  vs. α between our 
simulations and experiment (Fig. 7, Table S2): Only our simulation shows a variation in length scale 
with obstacle size. In contrast, our experimental data shows a similar gradient for all three molecular 
weights of PEG-DPPE. This suggests that in the experiment the size (but not number or extent) of 
defects produced are of a similar scale ( 150 nm) and are independent of the PEG molecular weight. 
This is in agreement with our observation that the anomalous diffusion is caused by the presence of 
bilayer defects, as seen in our AFM data, rather than the direct presence of PEG-DPPE lipids in the 
bilayer. The values extracted from AFM FWHMs are smaller by around a factor of 3. There is also a 
modest negative correlation between FWHM and excluded area fraction (see Fig. S6). 
The differences between experiment and simulation are most likely due to the different topologies for 
defects in the two cases: To preserve simplicity, defects in the simulation were simple circles. This is 
in contrast to our experimental AFM images (Fig. 2A) that show not circular, but rather interfacial 
defects for intermediate PEG-lipid concentrations. We therefore interpret this characteristic length 
scale as a descriptor of the barrier to diffusion. In our model, that is the scale associated with bilayer 
defects. 
To help compare measurements of anomalous diffusion from different methods with different 
timescales Saxton proposed eight criteria with which to judge the usefulness of any ‘positive control’ 
for anomalous diffusion. We reproduce the conclusions here, and direct the reader to the original 
paper for a comprehensive discussion (10): (1) Biologically relevant length and time scales; (2) A 
tuneable subdiffusion exponent with a well understood mechanism, such as percolation; (3) Simple to 
produce; (4) The anomalous regime to extend over 2-3 orders of magnitude, and if transient 
anomalous subdiffusion, that normal and anomalous regimes are distinct; (5) Tracers detectable by 
orthogonal methods, e.g. both NMR and fluorescence; (6) Transparent; (7) Either (i) spatially 
homogeneous, or (ii) inhomogeneous at all length scales for a fractal substrate; (8) Stable 
fluorescence. Overall our system satisfies these requirements. We also were able to compare SPT 
results from two different experimental techniques. However, we note as our model appears 
anomalous at all length scales, it only satisfies one sub-case of criterion (4). Our current experiment 
does not have distinct normal and anomalous regimes, defined by a single specific length scale. 
Conclusion 
By controlling SLB formation using PEGylated lipids we are able to produce bilayers with defined 
anomalous diffusive properties, dependent on the excluded area fraction and the presence of bilayer 
defects. Thus, we hope our work in part answers the call for a simple and reproducible experimental 
model, readily tuneable in anomaleity over the length scales observed in vivo. This study also opens 
the way to further experiments that exclude membrane area using more complex methods than the 
simple inclusion of PEG-lipids presented here. 
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Figure 1: Experimental scheme and raw data. (A) Cartoon of supported lipid bilayer formation. 
Fusion of small unilamellar vesicles containing PEGylated lipids creates supported lipid bilayers on 
glass. As the mole fraction of PEGylated lipids increases (left - low, right - high), defects form in the 
bilayer that that act as obstacles, generating anomalous diffusion. (B) AFM shows an increase in 
defect area fraction with increasing mol% PEG-(2K)DPPE (scale 500 nm). (C&D)Representative 
single-particle tracking of smTIRF (C) and iSCAT D) images (scale 10 μ m and 1 μ m, respectively). 
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Note iSCAT and smTIRF experiments require different magnifications, hence different image sizes 
and thus scale bars. Example extracted particle tracks are shown in orange. 
Figure 2: Variation in SLB anomalous diffusion with mol% PEG-DPPE. Logarithmic plots of 
2Δ / 4Δr t vs.Δt  have a gradient corresponding to the anomalous exponent, α. (A) For smTIRF 
anomalous sub-diffusion increased as the mol% PEG(2K)-DPPE was increased from 0 (black) to 5 
(yellow). (B) A similar variation of α using iSCAT to access shorter timescales was observed for 0 
(black) to 2.6 (red) mol% PEG(2K)-DPPE. (C&D) Variation of α and Γ  with mol% PEG-DPPE. 
PEG(1K)- (blue triangles), PEG(2K)- (red circles) and PEG(5K)-DPPE (green squares) including 
both smTIRF (open markers, solid fit lines) and iSCAT data (closed markers, dashed fit lines). Error 
bars (grey) throughout represent standard errors. Fig. S1 provides expanded legends for these plots. 
Figure 3: Variation in SLB anomalous diffusion with excluded area fraction. Image auto-
thresholding (see Methods) was used to determine the excluded area fraction from AFM images. 
Sigmoid fitting of excluded area fraction vs. mol% PEG-DPPE provides a calibration curve to convert 
mol% PEG-DPPE data in Fig. 2 to excluded area fraction; for PEG(1K)- (blue triangles), PEG(2K)- 
(red circles) and PEG(5K)-DPPE (green squares). Variation of α (B) and Γ  (C) with excluded area 
fractions including both smTRIF (open markers, solid fit lines) and iSCAT data (closed markers, 
dashed fit lines). Error bars (grey) throughout represent standard errors. 
Figure 4: Bilayer patches cause anomalous behaviour. (A) A SLB exhibiting anomalous 
behaviour (DOPC; 2.6% PEG(2K)-DPPE, red) was incubated with DOPC SUVs. SUVs ruptured 
within the defects repaired the bilayer and returned normal diffusion (grey). (B) FRAP shows similar 
behaviour, with 2.6% PEG(2K)-DPPE bilayers exhibiting a large slow and immobile fraction (red). 
Upon addition of DOPC SUVs, diffusion again recovers ( 1.75μD m 2  s 1 , mobile fraction 0.99, 
grey)) to values comparable to a pure DOPC bilayer ( 1.81μD m 2  s 1 , mobile fraction 1.00, 
black). 
Figure 5: Defect-free membranes show normal diffusion. DIBs were used to create unsupported 
lipid bilayers and confirm PEG-lipids alone do not result in anomalous behaviour. (A) Cartoon of DIB 
experiment. (B) DOPC DIBs containing PEG-DPPE and 
610  mol% TR-DHPE) were generated. 
Here, single-particle tracking using smTIRF showed normal diffusion for 0 (black), 2.6 (red) and 5.0 
(yellow) mol% PEG(2K)-DPPE. 
Figure 6: Monte Carlo simulations of anomalous diffusion. (A) Schematic of the unit cell. (B) 
Diffusion analysis of the resultant tracks showed similar behavior to experiment ( 500R  nm, 
3μD m 2  s 1 ). (C&D) A similar trend to experiment was also present for α and Γ  for R  150 
nm, 500 nm and 1 μ m (grey triangles, black circles, teal squares respectively). 
Figure 7: Anomalous scaling supports as expected from 3. (A) Plots of 10log Γ / D vs.α show 
the expected linear relation, dependent on obstacle size; shown for R  150 nm, 500 nm and 1 μ m 
(grey triangles, black circles, teal squares respectively). (B) Similar plots for our experimental data 
show an essentially static linear relationship for different PEG lengths. PEG(1K)- (blue triangles), 
PEG(2K)- (red circles) and PEG(5K)- (green squares). 
Figure 8: Measured vs. target α.  PEG-DPPE mole fractions were determined from target α 
values, predicted using our sigmoid fit of αvs. mol% PEG-DPPE (Fig. 2C). Analysis of SPT from 
these bilayers then returned our experimentally-measured α. Data is shown for PEG1K (blue 
triangles), PEG2K (red circles), and PEG5K (green squares). The root mean squared standard 
deviation between measured and target α was 0.065. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
C
B
0.0 2.0 2.6 3.0 5.0 mol%H
ei
gh
t /
 n
m
0.0                  2.0                   2.6                  3.0                  5.0 mol%10
0
A
D
10 µm 1 µm
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPTA B
C D
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
A B C
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
BA
BA
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
BA
BA
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
BA
BA
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
BA
BA
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
BA
BA
BA
+ SUVs
+ SUVs
BA
+ SUVs
+ SUVs
BA
BA
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
A
C
B
D
s
A
C
B
D
s
A
C
B
D
s
A
C
B
D
s
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
A B
A B
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
0 . 0 0 . 2 0 . 4 0 . 6 0 . 8 1 . 0
0 . 0
0 . 2
0 . 4
0 . 6
0 . 8
1 . 0
Mea
sure
d 
T a r g e t  
